December 2019

Judgment Call: Exploring Treatment Tactics in Clinically Isolated Syndrome

January 02, 2020

Features

More aggressive strategies in the treatment of multiple sclerosis have created an opportunity for physicians to refine the way they address a first demyelinating event, and perhaps change the course of disease.

Eisai Stays the Course on Amyloid Despite Setbacks

December 30, 2019

Clinical Viewpoint

The vice president and chief medical officer of the Neurology Business Group at Eisai discussed the company's decision to continue efforts on amyloid therapy despite prior setbacks.